View Post

Measuring tumor infiltrating lymphocytes predicts long term outcomes for type of early breast cancer

In In The News by Barbara Jacoby

By: Queen Mary, University of London From: medicalxpress.com Researchers from Queen Mary University London and Emory University used a novel AI-based analytic tool to better understand how tumor infiltrating lymphocytes (TILs) can predict which cases of Ductal Carcinoma in Situ (DCIS) would go on to become invasive breast cancer. DCIS is a form of early breast cancer, where some cells …

View Post

Team highlights long-term impact of socioeconomic inequalities on quality of life for women after breast cancer

In In The News by Barbara Jacoby

By: University of Geneva From: medicalxpress.com When it comes to health, inequalities can be seen at every level for women with breast cancer: prevention, screening, diagnosis, treatment, and survival. But what about their quality of life? A team from the University of Geneva (UNIGE), the University Hospitals of Geneva (HUG), Inserm, and Gustave Roussy has tracked nearly 6,000 women diagnosed …

View Post

Hormonal treatment provides long-term benefit for premenopausal women with breast cancer

In In The News by Barbara Jacoby

Source: Karolinska Institutet From: news-medical.net To investigate the long-term benefit of hormone-lowering treatment, researchers at Karolinska Institutet in Sweden have done a 20-year follow-up of premenopausal women with breast cancer. The study, published in the Journal of Clinical Oncology, indicates that the treatment provides protection even after a longer period of time and that different patients seem to benefit from …

View Post

Tumor size, grade impact long-term breast cancer distant recurrence risk

In In The News by Barbara Jacoby

By: Laura Cowen From: medwirenews.com Tumor size and grade are the strongest predictors of long-term distant recurrence free survival in people with lymph node-negative, estrogen receptor (ER)-positive, HER2-negative breast cancer, show 25-year data from the STO-3 trial. The secondary analysis, by Linda Lindström (Karolinska Institutet, Stockholm, Sweden) and colleagues, also revealed that individuals with larger tumors, lower tumor grades, and …